CEUEX
Price
$60.64
Change
-$0.15 (-0.25%)
Updated
Jul 2 closing price
Net Assets
143.2B
CIGOX
Price
$29.59
Change
-$0.60 (-1.99%)
Updated
Jul 2 closing price
Net Assets
359.21M
Interact to see
Advertisement

CEUEX vs CIGOX

CEUEX vs CIGOX Comparison Chart in %
View a ticker or compare two or three
VS
CEUEX vs. CIGOX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUEX is a Buy and CIGOX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUEX has more cash in the bank: 143B vs. CIGOX (359M). CEUEX pays higher dividends than CIGOX: CEUEX (2.44) vs CIGOX (0.40). CEUEX was incepted earlier than CIGOX: CEUEX (24 years) vs CIGOX (8 years). CIGOX (1.13) and CEUEX (1.09) have similar cost to investors . CIGOX is a more actively managed with annual turnover of: 170.00 vs. CEUEX (50.00). CIGOX has a lower initial minimum investment than CEUEX: CIGOX (0) vs CEUEX (250). CIGOX annual gain was more profitable for investors over the last year : 20.28 vs. CEUEX (6.13). CIGOX return over 5 years is better than : 2.46 vs. CEUEX (-5.70).
CEUEXCIGOXCEUEX / CIGOX
Total Expense Ratio1.090.86127%
Annual Report Gross Expense Ratio1.091.1396%
Fund Existence24 years8 years-
Gain YTD3.72927.05014%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets143B359M39,833%
Annual Yield % from dividends2.440.40612%
Returns for 1 year6.1320.2830%
Returns for 3 years19.9256.9935%
Returns for 5 years-5.702.46-231%
Returns for 10 years55.76N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNORX39.530.38
+0.97%
Easterly Snow Long/Short Opportunity R6
CDEYX21.210.09
+0.43%
Columbia Intrinsic Value Institutional 3
MCTRX25.930.08
+0.31%
NYLI Income Builder Class C
LRSCX16.94-0.13
-0.76%
Lord Abbett Small Cap Value A
FEMSX30.76-0.61
-1.94%
Fidelity Series Emerging Markets Opps